Angina market insights and analysis by type, diagnosis, treatment, end-users –forecast till 2030. Throughout the projected period, the prevalence of angina and coronary heart illnesses is expected to increase, as are healthcare costs and the population's ageing and obesity rates. The market expansion, however, is constrained by low per capita healthcare spending and high prices for therapeutic operations like coronary bypass surgery.

 Key Players

Some of the major market players in the global angina market are Anthera (U.S.), Taxus Cardium (U.S.), Astellas Pharma (Japan), Sanofi (France), Bayer AG (Germany), Merck Co., Inc. (U.S.), Torrent Pharmaceuticals Limited (India), Huya Bioscience International (U.S.), Viromed Co. Ltd. (South Korea), Baxter (U.S.), and others.

Segmentation

The global angina market trends is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of type, the market is segmented into angina pectoris, unstable angina, prinzmetal angina, and others.

On the basis of diagnosis, the market is categorized into imaging, blood test, stress test, and others. The imaging segment is sub-segmented into electrocardiogram, chest X-ray, cardiac computerized tomography scan, cardiac MRI, and others. The blood test segment is sub-segmented into cholesterol test, low-density lipoprotein test, triglycerides test, and others.

On the basis of treatment, the market is segmented into lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, and others. The medication segment is sub-segmented into aspirin, clot-preventing drugs, statins, ranolazine, and others. The clot-preventing drugs segment is further segmented into clopidogrel, prasugrel, and others.

On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, academic institutes, and others.

Regional Analysis

America dominates the global angina market. This can be attributed to the presence of a well-developed healthcare sector and a huge patient population for coronary heart diseases. Additionally, key players such as Merck Co., Inc. and Baxter within the region fuel the market growth. Europe stands second in the global market for angina. Availability of funds for research, growing number of obese and patient population, and the presence of developed economies such as France, Italy, and Germany within the region are the major drivers for the market growth within the region.

A burgeoning healthcare industry and the presence of developing nations like China and India make Asia Pacific the region with the highest growth, according to estimates. Also, the market is anticipated to grow faster than average during the forecast period as a result of factors including growing healthcare costs and favourable government policies. Africa and the Middle East have the smallest market shares. This is explained by the existence of weak economies, strict governmental regulations, and low healthcare spending per capita, particularly in the African continent. The Middle East currently controls the majority of the regional market.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com